ICU MEDICAL INC (ICUI)
US44930G1076 - Common Stock
Taking everything into account, ICUI scores 3 out of 10 in our fundamental rating. ICUI was compared to 192 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ICUI have multiple concerns. ICUI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ICUI had positive earnings in the past year.
ICUI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.68%, ICUI is in the better half of the industry, outperforming 70.26% of the companies in the same industry.
ICUI has a Return On Equity of -1.40%. This is in the better half of the industry: ICUI outperforms 69.74% of its industry peers.
ICUI's Return On Invested Capital of 1.30% is fine compared to the rest of the industry. ICUI outperforms 70.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 8.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.68% | ||
| ROE | -1.4% | ||
| ROIC | 1.3% |
ROA(3y)1.05%
ROA(5y)2.81%
ROE(3y)0.48%
ROE(5y)2.91%
ROIC(3y)2.84%
ROIC(5y)5.09%
1.3 Margins
Looking at the Operating Margin, with a value of 2.84%, ICUI is in the better half of the industry, outperforming 70.26% of the companies in the same industry.
ICUI's Operating Margin has declined in the last couple of years.
ICUI's Gross Margin of 32.75% is on the low side compared to the rest of the industry. ICUI is outperformed by 70.77% of its industry peers.
In the last couple of years the Gross Margin of ICUI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.84% | ||
| PM (TTM) | N/A | ||
| GM | 32.75% |
OM growth 3Y-34.03%
OM growth 5Y-25.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-4.26%
2. Health
2.1 Basic Checks
ICUI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ICUI has more shares outstanding
ICUI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ICUI has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.64, we must say that ICUI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ICUI (1.64) is comparable to the rest of the industry.
The Debt to FCF ratio of ICUI is 22.50, which is on the high side as it means it would take ICUI, 22.50 years of fcf income to pay off all of its debts.
ICUI has a better Debt to FCF ratio (22.50) than 71.28% of its industry peers.
ICUI has a Debt/Equity ratio of 0.74. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
ICUI has a worse Debt to Equity ratio (0.74) than 74.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 22.5 | ||
| Altman-Z | 1.64 |
ROIC/WACC0.14
WACC9.58%
2.3 Liquidity
ICUI has a Current Ratio of 2.53. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
ICUI's Current ratio of 2.53 is on the low side compared to the rest of the industry. ICUI is outperformed by 61.03% of its industry peers.
A Quick Ratio of 1.06 indicates that ICUI should not have too much problems paying its short term obligations.
The Quick ratio of ICUI (1.06) is worse than 81.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.53 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
ICUI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.36%.
ICUI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.22% yearly.
The Revenue has decreased by -0.92% in the past year.
The Revenue has been growing by 10.04% on average over the past years. This is quite good.
EPS 1Y (TTM)3.36%
EPS 3Y-1.76%
EPS 5Y-5.22%
EPS growth Q2Q-1.88%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y21.13%
Revenue growth 5Y10.04%
Revenue growth Q2Q1.71%
3.2 Future
ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.32% yearly.
ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.98% yearly.
EPS Next Y-28.66%
EPS Next 2Y1.11%
EPS Next 3Y7.75%
EPS Next 5Y18.32%
Revenue Next Year2.97%
Revenue Next 2Y3.38%
Revenue Next 3Y3.22%
Revenue Next 5Y3.98%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ICUI is valuated correctly with a Price/Earnings ratio of 14.03.
Based on the Price/Earnings ratio, ICUI is valued cheaper than 92.82% of the companies in the same industry.
When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (24.84), we can say ICUI is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 19.67, the valuation of ICUI can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 87.18% of the companies listed in the same industry.
ICUI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.35, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 19.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaper than 90.26% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICUI is valued cheaper than 85.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.87 | ||
| EV/EBITDA | 12.58 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3Y7.75%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ICU MEDICAL INC
NASDAQ:ICUI (4/26/2024, 7:00:02 PM)
After market: 94.84 0 (0%)94.84
+0.31 (+0.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.31B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 19.67 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.68% | ||
| ROE | -1.4% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 2.84% | ||
| PM (TTM) | N/A | ||
| GM | 32.75% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.53 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)3.36%
EPS 3Y-1.76%
EPS 5Y
EPS growth Q2Q
EPS Next Y-28.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y21.13%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y